Aurobindo Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARM, and what generic and branded alternatives to AUROBINDO PHARM drugs are available?
AUROBINDO PHARM has four hundred and seventy-six approved drugs.
There are nineteen tentative approvals on AUROBINDO PHARM drugs.
Summary for Aurobindo Pharm
| US Patents: | 0 |
| Tradenames: | 368 |
| Ingredients: | 342 |
| NDAs: | 476 |
| Patent Litigation for Aurobindo Pharm: | See patent lawsuits for Aurobindo Pharm |
| PTAB Cases with Aurobindo Pharm as petitioner: | See PTAB cases with Aurobindo Pharm as petitioner |
Drugs and US Patents for Aurobindo Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 091052-001 | Feb 8, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Aurobindo Pharma Ltd | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 214728-001 | Mar 31, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Aurobindo Pharma Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 203820-002 | Jan 22, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Aurobindo Pharma | RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 204310-001 | Aug 28, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Try a Trial |
| Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Try a Trial |
| Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AUROBINDO PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
